Lista de obras - Esther MM. Ooi - Dominio Público Uruguay

Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.

artículo científico publicado en 2011

Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations

artículo científico publicado en 2011

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

artículo científico publicado en 2008

Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration

scientific article published on 01 December 2019

Association Between Plasma Neutrophil Gelatinase-Associated Lipocalin and Cardiac Disease Hospitalizations and Deaths in Older Women

artículo científico publicado en 2019

Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment

artículo científico publicado en 2015

Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.

artículo científico publicado en 2009

Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.

artículo científico publicado en 2008

Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.

artículo científico publicado en 2013

Balancing the cardiometabolic benefits and risks of statins ⬇️

artículo científico publicado el 11 de agosto de 2012

Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III.

scientific article published on 21 June 2009

Consumption of a whey protein-enriched diet may prevent hepatic steatosis associated with weight gain in elderly women.

artículo científico publicado en 2014

Demystifying the management of hypertriglyceridaemia.

artículo científico publicado en 2013

Dietary fatty acids and lipoprotein metabolism: new insights and updates

artículo científico

Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.

artículo científico publicado en 2007

Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?

artículo científico publicado en 2012

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome

artículo científico publicado en 2008

Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome

artículo científico publicado en 2007

Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome

artículo científico publicado en 2014

Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome

artículo científico publicado en 2007

Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.

artículo científico publicado en 2013

Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects

artículo científico publicado en 2010

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update

artículo científico publicado en 2015

Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet

artículo científico publicado en 2010

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome

artículo científico publicado en 2012

Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial

artículo científico publicado en 2020

Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.

artículo científico publicado en 2012

Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity

artículo científico publicado en 2010

Effects of atorvastatin on human C-reactive protein metabolism.

artículo científico publicado en 2012

Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus

artículo científico publicado en 2015

Elevated Remnant Cholesterol in 25-Hydroxyvitamin D Deficiency in the General Population

artículo científico publicado en 2014

Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness

artículo científico publicado en 2013

Familial Hypercholesterolaemia and Lipoprotein(a) Phenotypes in a Community-Based Cohort: Associations with Carotid Intima-Media Thickness, Focal Plaque and Cardiovascular Outcomes

Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease.

artículo científico publicado en 2012

Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.

artículo científico publicado en 2006

Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentration

artículo científico publicado en 2019

Genetic determinants of apolipoprotein B-100 kinetics

scientific article published on April 2010

HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio?

artículo científico publicado en 2014

High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics

scientific article published on 20 December 2005

High-density lipoprotein apolipoprotein A-I kinetics in obesity

artículo científico publicado en 2005

High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies

artículo científico publicado en 2006

Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin

scientific article published on 20 August 2007

Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.

artículo científico publicado en 2013

Linkage between C-reactive protein and triglyceride-rich lipoprotein metabolism

artículo científico publicado en 2012

Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease

scientific article published on 13 December 2018

Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque

artículo científico publicado en 2018

Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity

artículo científico publicado en 2011

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

artículo científico publicado en 2017

Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans

artículo científico publicado en 2015

More data needed on curcuminoids in hypertriglyceridaemia.

artículo científico publicado en 2014

Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity

scientific article published on 11 February 2010

Nutrition and metabolism: new insights into lifestyle modifications and pharmacotherapy for managing cardiometabolic risk

artículo científico publicado en 2008

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.

artículo científico publicado en 2013

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

artículo científico publicado en 2011

Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.

artículo científico publicado en 2009

Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women's Health Initiative observational study

artículo científico publicado en 2014

Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo

artículo científico publicado en 2006

Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?

artículo científico publicado en 2009

Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.

artículo científico publicado en 2009

Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome

artículo científico publicado en 2006

Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner

artículo científico publicado en 2015

Socio‐economic disparity, access to care and patient‐relevant outcomes after kidney allograft failure

artículo científico publicado en 2021

The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.

artículo científico publicado en 2013

Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo.

artículo científico publicado en 2009

Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.

artículo científico publicado en 2016

Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men

scientific article published on 30 December 2008

Lista de obras de Esther MM. Ooi

Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.

Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration

Association Between Plasma Neutrophil Gelatinase-Associated Lipocalin and Cardiac Disease Hospitalizations and Deaths in Older Women

Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment

Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.

Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.

Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.

Balancing the cardiometabolic benefits and risks of statins ⬇️

Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III.

Consumption of a whey protein-enriched diet may prevent hepatic steatosis associated with weight gain in elderly women.

Demystifying the management of hypertriglyceridaemia.

Dietary fatty acids and lipoprotein metabolism: new insights and updates

Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.

Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome

Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome

Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome

Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome

Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.

Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update

Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome

Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial

Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.

Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity

Effects of atorvastatin on human C-reactive protein metabolism.

Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus

Elevated Remnant Cholesterol in 25-Hydroxyvitamin D Deficiency in the General Population

Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness

Familial Hypercholesterolaemia and Lipoprotein(a) Phenotypes in a Community-Based Cohort: Associations with Carotid Intima-Media Thickness, Focal Plaque and Cardiovascular Outcomes

Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease.

Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.

Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentration

Genetic determinants of apolipoprotein B-100 kinetics

HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio?

High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics

High-density lipoprotein apolipoprotein A-I kinetics in obesity

High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies

Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin

Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.

Linkage between C-reactive protein and triglyceride-rich lipoprotein metabolism

Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease

Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque

Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans

More data needed on curcuminoids in hypertriglyceridaemia.

Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity

Nutrition and metabolism: new insights into lifestyle modifications and pharmacotherapy for managing cardiometabolic risk

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.

Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women's Health Initiative observational study

Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo

Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?

Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.

Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome

Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner

Socio‐economic disparity, access to care and patient‐relevant outcomes after kidney allograft failure

The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.

Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo.

Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.

Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men